Evidence map›Paper›PMID 37129705›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2023

A novel water-soluble thiosemicarbazone Schiff base ligand and its complexes as potential anticancer agents and cellular fluorescence imaging.

Sima Feizpour, Seyed Abolfazl Hosseini-Yazdi, Elham Safarzadeh, Behzad Baradaran, Michal Dusek, Morgane Poupon

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Transmetalation in Cancer Pharmacology.International journal of molecular sciences · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Sima FeizpourDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, 51666-14766, Iran.
Seyed Abolfazl Hosseini-YazdiDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, 51666-14766, Iran. hosseiniyazdi@tabrizu.ac.ir.ORCID 0000-0002-0566-2287
Elham SafarzadehDepartment of Microbiology and Immunology, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Behzad BaradaranImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, 5166614731, Iran.
Michal DusekInstitute of Physics of the Czech Academy of Sciences, Na Slovance 2, 182 21, Prague 8, Czech Republic.
Morgane PouponInstitute of Physics of the Czech Academy of Sciences, Na Slovance 2, 182 21, Prague 8, Czech Republic.
Czech Academy of Sciences · CZUniversity of Tabriz · IRArdabil University of Medical Sciences · IRTabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel fluorescent ligand (H

Indexed as

Antineoplastic AgentsCoordination ComplexesThiosemicarbazonesCopperFerric CompoundsHumansLigandsSchiff BasesAntineoplastic AgentsCoordination ComplexesCopperFerric CompoundsLigandsSchiff BasesThiosemicarbazonesAnticancer activityApoptosisCell cycleCytotoxicityFlow cytometryX-ray crystallography

Identifiers

PMID37129705
OpenAlexW4367669619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.